Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma((R))) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System.

March
SunMonTueWedThuFriSat
2324252627281234567891011121314151617181920212223242526272829303112345
March
SunMonTueWedThuFriSat
2324252627281234567891011121314151617181920212223242526272829303112345
Copyright © Ark Medical Solutions Inc. All Rights Reserved.